latest IPO in India: Positive 5‑Point Jump – Aakaar Medical Technologies Ltd
Latest IPO in India has spotlighted Aakaar Medical Technologies Ltd, a Mumbai‑based SME in cosmetic dermatology and medical aesthetics. This article dives into the IPO details, price band, subscription, promoter holdings, GMP, strengths, risks and more—all in a reader-friendly format.
Company Overview
Founded in 2013, Aakaar offers over 150 SKUs, including homecare and professional skincare products, injectables, hair-care formulations, and aesthetic devices. It sources premium brands domestically and internationally (Korea, Spain, Italy, Austria) and distributes through 90 sales and service professionals across 15 states.
IPO Timeline
- Subscription opens: 20 June 2025
- Subscription ends: 24 June 2025
- Allotment finalised: 25 June 2025
- Shares credited: 26 June 2025
- Listing date: 27 June 2025 (NSE SME)
Price Band
₹68 – ₹72 per share, with a face value of ₹10
Lot Size
Each lot consists of 1,600 shares, requiring an investment of ₹1,15,200 at the upper band.
Key Dates
- IPO Open Date: 20 June 2025
- IPO Close Date: 24 June 2025
- Allotment: 25 June 2025
- Demat Credit: 26 June 2025
- Listing Date: 27 June 2025
Financials
| Year | Revenue (₹ Cr) | PAT (₹ Cr) |
|---|---|---|
| FY23 | 32.78 | 2.15 |
| FY24 | 46.11 | 2.87 |
| FY25 | 61.58 | 6.04 |
Strengths
- Diverse product mix: Devices, injectables, skin & hair care.
- Pan-India distribution: 90-strong sales and service force.
- Strong financial growth: Revenue grew 33% YoY, PAT more than doubled.
- Experienced promoters and anchor support: ₹7.68 Cr raised ahead of IPO.
Risks
- High import dependency.
- No in-house manufacturing base.
- Geographic concentration in Maharashtra and Karnataka.
- Logistics reliance on third-party distributor (Parekh Integrated).
IPO Anchor Investors Details
Allocated ~10.67 lakh shares (~28.4% of offer) to anchor investors before the IPO.
IPO Promoter Holding Details
| Promoter | Pre‑IPO Holding (%) | Post‑IPO Holding (%) |
|---|---|---|
| Dilip Ramesh Meswani & Bindi Dilip Meswani | 91.11% | To be updated post‑allotment |
IPO Grey Market Premium (GMP)
| Date | GMP (₹) |
|---|---|
| As of 20 June 2025 | 0 |
Final Thoughts
Aakaar Medical’s IPO presents a strong growth story in a niche, high‑margin sector with solid financial performance and robust promoter backing. The nil GMP suggests a fair valuation. However, dependence on imports, outsourced manufacturing, and geographical concentration remain key watchpoints. Retail investors might consider subscribing for long-term gains, while monitoring competitive intensity and operational resilience.